Clinical Trial Update: Study Of Gemcitabine Plus AG-013736 Versus Gemcitabine For Advanced Pancreatic Cancer. [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing gemcitabine plus AG-013736 versus gemcitabine alone in advanced pancreatic ductal adenocarcinoma has completed, with results posted in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Ductal Adenocarcinoma

Drugs mentioned

• AG-013736
• Gemzar (gemcitabine)

Snippet

Sponsor: Pfizer | Conditions: Carcinoma, Pancreatic Ductal | Phase 3 | Status: COMPLETED | Results posted: 2012-07-16